Veteran medtech executive Scott Huennekens is out as CEO of Verb Surgical, the robot-assisted surgery joint venture between Johnson & Johnson (NYSE:JNJ) and Google parent Alphabet (NSDQ:GOOGL), which today installed Kurt Azarbarzin in the corner office. Azarbarzin, himself a medical device industry longtimer, was co-founder & CEO of SurgiQuest until its 2016 acquisition by ConMed (NSDQ:CNMD), where he was named […]
Nevro taps ex-Thoratec CEO Grossman | Personnel Moves, March 20, 2019
Nevro Corp. (NYSE:NVRO) said yesterday that it named former Thoratec CEO Keith Grossman to replace president & CEO Rami Elghandour after striking a deal with one of its investors, Broadfin Capital. Grossman re-joined Thoratec after taking over at Conceptus in December 2011 and leading it to a $1.1 billion sale to Bayer in June 2013 (he’d […]
Globus Medical gains on Street-beating prelims | Wall Street Beat
Globus Medical (NYSE:GMED) shares closed up yesterday after the orthopedics company reported preliminary fourth-quarter and 2018 sales numbers that beat the consensus forecast on Wall Street. Audubon, Pa.-based Globus said it expects to post Q4 revenues of $195.5 million and full-year sales of $712.5 million; analysts on The Street were looking for quarterly sales of $188.2 million and […]
Analyst downgrades pressure medtech stocks
Several medical device companies took hits yesterday after analysts on Wall Street downgraded their stocks, on a day when the major market indices each closed up a hair, and even medtech firms that enjoyed upgrades came under pressure. Globus Medical (NYSE:GMED) suffered the most after Morgan Stanley analyst David Lewis cut his rating on the stock from […]
Fujifilm Sonosite taps Ueda as chair, CEO | Personnel Moves – August 9, 2018
Fujifilm‘s (TSE:4901) SonoSite subsidiary said earlier this week it appointed Fujifilm vet and current Fujifilm Medical Systems USA and Fujifilm New Development USA prez Takaaki Ueda as its new chair and CEO. Previously, Ueda has also served as Fujifilm global endoscopy systems division GM, the company said. Ueda will replace the departing Masayuki Higuchi who […]
Tactile Medical shareholders ready $109 million offering
Tactile Systems Technology said this week that its investors have priced a new offering, looking to raise approximately $109 million. In the offering, investors in the Minneapolis, Minn.-based company will look to offer 3.3 million shares of common stock at approximately $33 per share. The offering will also include an underwriters option to purchase an additional […]
Tactile Systems launches Flexitouch lymphedema device
Tactile Systems Technology said today it launched its Flexitouch device designed to treat lymphedema of the head and neck, touting it as the 1st and only pneumatic compression therapy approved for the condition. The Flexitouch device is designed to use pneumatic compression to stimulate the lymphatic system to deliver non-invasive, self-delivered therapy for lymphedema, which is […]
Tactile Systems reduces IPO to $46m
Leg compression device developer Tactile Systems Technology reduced its initial public offering to $46 million. Those estimates are down approximately 24% from the $60 million it said it hoped to bring in in June, which was 30% less than the $86 million projection the company put up when it registered the IPO in January. The company said on […]
Tactile Systems sets terms for $60m IPO
Leg compression device developer Tactile Systems Technology set the terms for its initial public offering today, saying it plans to float 4 million shares at $14 to $16 apiece. At the midpoint, that would fetch $60 million, or 30% less than the $86 million projection the company put up when it registered the IPO in January. […]
Compression device dev Tactile Systems files for $86m IPO
Leg compression device developer Tactile Systems Technology is aiming for to get a leg up by going public, registering for an $86 million initial public offering, according to an SEC filing posted today. Tactile Systems produces the Flexitouch fully-automated pneumatic compression device designed to treat lymphedema, and the ACTitouch wearable compression device designed to treat […]
Tactile Systems touches $10M | Wall Street Beat
Tactile Systems Technology said it reeled in a $10.4 million Series B round led by Radius Ventures, with the proceeds to go toward acquiring "a leading new product" and patents for treating lymphedema, or fluid retention.
MassDevice Network
@MassDevice
LinkedIn
YouTube